Meanwhile, the CAV-1 expression level is also closely related to the progression, distant metastasis, therapeutic resistance, and different outcomes of the patients [15‒19] , especially the subtype of epidermal growth factor receptor (EGFR)-positive breast cancer patients[20]. Here, CAV1 is linked to breast carcinoma.